Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.05
-0.10
(-1.40%)
At close: February 28 at 4:25:36 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
327,062
75,544
109,230
71,298
Total Liabilities Net Minority Interest
131,052
68,355
83,297
53,398
Total Equity Gross Minority Interest
196,010
7,189
25,933
17,900
Total Capitalization
240,707
34,809
60,539
51,882
Common Stock Equity
196,010
7,189
25,933
17,900
Capital Lease Obligations
539
1,384
213
--
Net Tangible Assets
170,987
-17,837
-6,164
-14,203
Working Capital
215,931
4,050
43,221
18,260
Invested Capital
250,935
44,966
70,601
51,894
Tangible Book Value
170,987
-17,837
-6,164
-14,203
Total Debt
55,464
39,161
44,881
33,994
Net Debt
--
10,827
--
4,698
Share Issued
62,928.82
22,301.19
16,755.45
14,307.47
Ordinary Shares Number
62,917.48
22,301.19
16,755.45
14,307.47
Treasury Shares Number
11.34
12
8.60
12.80
12/31/2020 - 11/7/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
25I.F ImmuPharma plc
0.0265
-37.65%
SANNz.XC
0EVI.IL Innate Pharma S.A.
2.1375
-3.93%
VTRO
KAPA Kairos Pharma, Ltd.
1.1900
-1.65%
AFMD Affimed N.V.
1.0300
-0.96%
MBX MBX Biosciences, Inc.
9.60
-2.24%
ZBIO Zenas BioPharma, Inc.
7.01
+6.05%
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
CSBR Champions Oncology, Inc.
10.28
+0.59%